Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
To evaluate the predictive value and mechanism of inflammatory factors in peripheral blood on the prognosis of patients, and to explore the influencing factors of inflammation and tumor microenvironment on the efficacy of neoadjuvant chemotherapy combined with immunotherapy for esophageal cancer. To explore the predictors of neoadjuvant therapy in patients with esophageal squamous cell carcinoma.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• The patient's age between 18 to 80 years old; Esophageal squamous cell carcinoma with definite pathological diagnosis and II-IVA clinical stage Preoperative neoadjuvant chemotherapy combined with immunotherapy The score of eastern cooperative oncology group is 0 \
Locations
Other Locations
China
Renmin hosptial of Wuhan University
RECRUITING
Wuhan
Contact Information
Primary
Yong Shun Chen
yongshun2007@163.com
86+153 2712 2084
Time Frame
Start Date: 2023-05-04
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 10
Treatments
Neoadjuvant chemotherapy combi
Related Therapeutic Areas
Sponsors
Leads: Renmin Hospital of Wuhan University